Virtual Medicinal Product (VMP) - Natalizumab 300mg/15ml solution for infusion vials

Navigation

Name Details

Name Start Date End Date
Current Name Natalizumab 300mg/15ml solution for infusion vials 19-01-2009
Previous Name Natalizumab 300mg/15ml solution for injection vials 19-07-2006 18-01-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
15.0
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Solution for infusion
Ontology Form/Route
solutioninfusion.intravenous
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
L04AG03
BNF Start Date End Date
Current BNF 08020400 Start Date 04-04-2022 End Date
Previous BNF 08020400 Start Date 11-04-2007 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36030311000001108 29-10-2018
414806008 20-07-2006 28-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Natalizumab Based on Ingredient Substance 20 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial